Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07211334
Recruiting Observational

High Intensity Interval Training Versus Moderate Intensity Continuous Training in Frail Elderly

NCT07211334 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Grenoble
Phase
Observational
Started
2025-12-11
Last updated
2026-05-05

Condition(s) studied

Frail Elderly

Investigational drug(s) / intervention(s)

Exercise Training

Exercise Training: Adapted High Intensity Interval Training (HIIT), Moderate-Intensity Continuous training (MICT), therapeutic education workshops to help people become independent regarding their program

Study summary

The assessment and systematic integration of physical activity into the care pathway of frail elderly people is essential to prevent loss of independence and improve the quality of life of this population. This project, which is part of routine care, aims to evaluate the practices and, in particular, the effects of different types of physical exercise currently in use at the Health and Sport Center of the Grenoble Alpes University Hospital. It therefore aims to optimize professional practices without changing the standard care provided to patients. Recommendations regarding intensity during cardiorespiratory endurance training sessions (moderate to high, taking into account emotional factors) are broad and vary greatly in their application depending on the facilities that work with older adults. This project aims to compare the exercise methods used on ergocycle at Health and Sport Center of Grenoble Alpes University Hospital: high-intensity interval training (HIIT) vs. moderate-intensity continuous training (MICT) to reverse the functional decline that occurs in frail older adults.

Eligibility

Sex
ALL
Min age
70 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 70 or older; * Patients meeting at least 1 of 5 frailty criteria (Fried criteria; 2001); * Patient does not object to the analysis of anonymized data; * Person affiliated with social security; * Patient's ability to use an ergocycle safely; * Patients medically stable patients with no acute illness or recent decompensation that could be aggravated by exercise (at the physician's discretion). Exclusion Criteria: * Unstable medical conditions that may be aggravated by physical activity (as determined by a physician) * Musculoskeletal disorders and severe neurocognitive conditions that make it impossible to safely use the ergocycle or participate in the exercise program * individuals participating in other interventional studies or who have recently participated in an interventional study that could influence the results of this study * Persons referred to in Articles L1121-5 to L1121-8 of the public health code (corresponds to all protected persons: pregnant women, women in labor, breastfeeding mothers, persons deprived of their liberty by judicial or administrative decision, persons subject to legal protection measures)

Primary outcome measure(s)

  • Cardiorespiratory endurance (VO2peak) — At weeks 0, 8 and 24
    in mL/kg/min with an ergospirometer during a maximal progressive test

Trial sites (1)

FacilityCityRegionStatus
University Grenoble alpes Grenoble France Recruiting

More University Hospital, Grenoble trials in France

Osteosynthesis of Fibula Fractures With a Locked Thin Plate Starting soon
Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies Recruiting
Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema Recruiting
Cardiovascular Risk and Chronic Obstructive Pulmonary Disease Recruiting
Prevention Workshop to Address Bullying Behaviors in Schools Active, not recruiting

Other trials for the same condition

Advanced Practice Nurses for Fall Incidence PrevenTion in Very Old Robust Adults Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07211334 on ClinicalTrials.gov ↗ ← All trials in France